ARCALIS
Chemicals & Related Products · Japan · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Shimoota Kawauchisaku Minamisouma Shi Ha...Website
corp.arcalis.co.jpRevenue
$7.4 MillionIndustry
About ARCALIS
株式会社ARCALIS is a pioneering CDMO in Japan specializing in mRNA, established in 2021 as a joint venture between Accelread and Arcturus Therapeutics. The company provides drug discovery support and CMC development services to pharmaceutical and biotech companies, leveraging Arcturus's expertise in mRNA drug and vaccine research and manufacturing. With a fully integrated development service model, ARCALIS offers cGMP compliant mRNA and LNP manufacturing capabilities, including tailored mRNA design and production of up to 100g per batch. The company is expanding its facilities to enhance its production of mRNA-based therapeutics and vaccines, aiming to commercialize next-generation mRNA vaccines by 2024.Explore more
SIC Code 28,283NAICS Code 32,325Show more
ARCALIS Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
ARCALIS Tech Stack
A closer look at the technologies used by ARCALIS
See more technologies
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ARCALIS
Sign Up For FreeTo access detailed company insights
株式会社ARCALIS is a pioneering CDMO in Japan specializing in mRNA, established in 2021 as a joint venture between Accelread and Arcturus Therapeutics. The company provides drug discovery support and CMC development services to pharmaceutical and biotech companies, leveraging Arcturus's expertise in mRNA drug and vaccine research and manufacturing. Wit... Read More
